Moxetumomab Pasudotox-tdfk and Tofacitinib Citrate
Determining the interaction of Moxetumomab Pasudotox-tdfk and Tofacitinib Citrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Tofacitinib Extended-Release Tablets
- Moxetumomab Pasudotox-tdfk-Tofacitinib Tablets
- Moxetumomab Pasudotox-tdfk-Tofranil
- Moxetumomab Pasudotox-tdfk-Tofranil injection
- Moxetumomab Pasudotox-tdfk-Tofranil-PM
- Moxetumomab Pasudotox-tdfk-Tol-Tab
- Tofacitinib Citrate-Moxetumomab pasudotox-tdfk Intravenous
- Tofacitinib Citrate-Moxifloxacin
- Tofacitinib Citrate-Moxifloxacin (Systemic)
- Tofacitinib Citrate-Moxifloxacin Hydrochloride
- Tofacitinib Citrate-Moxifloxacin Injection
- Tofacitinib Citrate-Moxifloxacin Intravenous